736 related articles for article (PubMed ID: 12381268)
1. Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice.
Kok T; Bloks VW; Wolters H; Havinga R; Jansen PL; Staels B; Kuipers F
Biochem J; 2003 Feb; 369(Pt 3):539-47. PubMed ID: 12381268
[TBL] [Abstract][Full Text] [Related]
2. Induction of hepatic ABC transporter expression is part of the PPARalpha-mediated fasting response in the mouse.
Kok T; Wolters H; Bloks VW; Havinga R; Jansen PL; Staels B; Kuipers F
Gastroenterology; 2003 Jan; 124(1):160-71. PubMed ID: 12512040
[TBL] [Abstract][Full Text] [Related]
3. Editor's Highlight: Clofibrate Decreases Bile Acids in Livers of Male Mice by Increasing Biliary Bile Acid Excretion in a PPARα-Dependent Manner.
Zhang Y; Lickteig AJ; Csanaky IL; Klaassen CD
Toxicol Sci; 2017 Dec; 160(2):351-360. PubMed ID: 28973556
[TBL] [Abstract][Full Text] [Related]
4. Decreased Na+-dependent taurocholate uptake and low expression of the sinusoidal Na+-taurocholate cotransporting protein (Ntcp) in livers of mdr2 P-glycoprotein-deficient mice.
Koopen NR; Wolters H; Voshol P; Stieger B; Vonk RJ; Meier PJ; Kuipers F; Hagenbuch B
J Hepatol; 1999 Jan; 30(1):14-21. PubMed ID: 9927146
[TBL] [Abstract][Full Text] [Related]
5. Effects of bile salt flux variations on the expression of hepatic bile salt transporters in vivo in mice.
Wolters H; Elzinga BM; Baller JF; Boverhof R; Schwarz M; Stieger B; Verkade HJ; Kuipers F
J Hepatol; 2002 Nov; 37(5):556-63. PubMed ID: 12399219
[TBL] [Abstract][Full Text] [Related]
6. ABCG5/ABCG8-independent biliary cholesterol excretion in lactating rats.
Coy DJ; Wooton-Kee CR; Yan B; Sabeva N; Su K; Graf G; Vore M
Am J Physiol Gastrointest Liver Physiol; 2010 Jul; 299(1):G228-35. PubMed ID: 20413720
[TBL] [Abstract][Full Text] [Related]
7. Abcc6 deficiency in mice leads to altered ABC transporter gene expression in metabolic active tissues.
Ibold B; Faust I; Tiemann J; Gorgels TGMF; Bergen AAB; Knabbe C; Hendig D
Lipids Health Dis; 2019 Jan; 18(1):2. PubMed ID: 30611276
[TBL] [Abstract][Full Text] [Related]
8. Dietary cholesterol does not normalize low plasma cholesterol levels but induces hyperbilirubinemia and hypercholanemia in Mdr2 P-glycoprotein-deficient mice.
Voshol PJ; Koopen NR; de Vree JM; Havinga R; Princen HM; Elferink RP; Groen AK; Kuipers F
J Hepatol; 2001 Feb; 34(2):202-9. PubMed ID: 11281547
[TBL] [Abstract][Full Text] [Related]
9. Effect of phenobarbital on the expression of bile salt and organic anion transporters of rat liver.
Hagenbuch N; Reichel C; Stieger B; Cattori V; Fattinger KE; Landmann L; Meier PJ; Kullak-Ublick GA
J Hepatol; 2001 Jun; 34(6):881-7. PubMed ID: 11451172
[TBL] [Abstract][Full Text] [Related]
10. ABCG5 and ABCG8 require MDR2 for secretion of cholesterol into bile.
Langheim S; Yu L; von Bergmann K; Lütjohann D; Xu F; Hobbs HH; Cohen JC
J Lipid Res; 2005 Aug; 46(8):1732-8. PubMed ID: 15930516
[TBL] [Abstract][Full Text] [Related]
11. Cholestatic effect of large bilirubin loads and cholestasis protection conferred by cholic acid co-infusion: a molecular and ultrastructural study.
Labori KJ; Arnkvaern K; Bjørnbeth BA; Press CM; Raeder MG
Scand J Gastroenterol; 2002 May; 37(5):585-96. PubMed ID: 12059062
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the endothelin receptor antagonists ambrisentan, bosentan, macitentan, and sitaxsentan as hepatobiliary transporter inhibitors and substrates in sandwich-cultured human hepatocytes.
Lepist EI; Gillies H; Smith W; Hao J; Hubert C; St Claire RL; Brouwer KR; Ray AS
PLoS One; 2014; 9(1):e87548. PubMed ID: 24498134
[TBL] [Abstract][Full Text] [Related]
13. A nuclear receptor-mediated choleretic action of fibrates is associated with enhanced canalicular membrane fluidity and transporter activity mediating bile acid-independent bile secretion.
Nishioka T; Hyogo H; Numata Y; Yamaguchi A; Kobuke T; Komichi D; Nonaka M; Inoue M; Nabeshima Y; Ogi M; Iwamoto K; Ishitobi T; Ajima T; Chayama K; Tazuma S
J Atheroscler Thromb; 2005; 12(4):211-7. PubMed ID: 16141625
[TBL] [Abstract][Full Text] [Related]
14. Fibrates induce mdr2 gene expression and biliary phospholipid secretion in the mouse.
Chianale J; Vollrath V; Wielandt AM; Amigo L; Rigotti A; Nervi F; Gonzalez S; Andrade L; Pizarro M; Accatino L
Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):781-6. PubMed ID: 8615769
[TBL] [Abstract][Full Text] [Related]
15. Fibrates suppress bile acid synthesis via peroxisome proliferator-activated receptor-alpha-mediated downregulation of cholesterol 7alpha-hydroxylase and sterol 27-hydroxylase expression.
Post SM; Duez H; Gervois PP; Staels B; Kuipers F; Princen HM
Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1840-5. PubMed ID: 11701475
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of mdr2 gene by peroxisome proliferators in the mouse liver.
Miranda S; Vollrath V; Wielandt AM; Loyola G; Bronfman M; Chianale J
J Hepatol; 1997 Jun; 26(6):1331-9. PubMed ID: 9210621
[TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats.
Cherrington NJ; Slitt AL; Li N; Klaassen CD
Drug Metab Dispos; 2004 Jul; 32(7):734-41. PubMed ID: 15205389
[TBL] [Abstract][Full Text] [Related]
18. Effects of peroxisome proliferator-activated receptor alpha activation on pathways contributing to cholesterol homeostasis in rat hepatocytes.
Le Jossic-Corcos C; Duclos S; Ramirez LC; Zaghini I; Chevillard G; Martin P; Pineau T; Bournot P
Biochim Biophys Acta; 2004 Jul; 1683(1-3):49-58. PubMed ID: 15238219
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic activation of hepatic farnesoid X receptor prevents parenteral nutrition-associated cholestasis in mice.
El Kasmi KC; Ghosh S; Anderson AL; Devereaux MW; Balasubramaniyan N; D'Alessandro A; Orlicky DJ; Suchy FJ; Shearn CT; Sokol RJ
Hepatology; 2022 Feb; 75(2):252-265. PubMed ID: 34387888
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling.
Ide T; Shimano H; Yoshikawa T; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Nakakuki M; Yatoh S; Iizuka Y; Tomita S; Ohashi K; Takahashi A; Sone H; Gotoda T; Osuga J; Ishibashi S; Yamada N
Mol Endocrinol; 2003 Jul; 17(7):1255-67. PubMed ID: 12730332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
